GlaxoSmithKline PLC
05 January 2004
Directors' Interests
I give below details of changes in the directors' interests in the Ordinary
Shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 31 December 2003, the following non-executive Directors were provisionally
allocated the following awards over Ordinary Shares and ADSs in the Company
under the automatic share allocation arrangements for non-executive Directors
for the period of service from 1 October to 31 December 2003, as listed below.
Non Executive Director Ordinary Shares American Depository
Shares (ADS)
Sir Christopher Hogg 1,500
Dr Michele Barzach 250
Mr Lawrence Culp 125
Mr Crispin Davis 250
Sir Peter Job 250
John McArthur 125
Donald McHenry 125
Sir Ian Prosser 250
Dr Ronaldo Schmitz 250
Dr Lucy Shapiro 125
Sir Robert Wilson 166.6667
At the same time the following non-executive Directors were provisionally
allocated the following awards over Ordinary Shares and ADSs in the Company
under the share election element of the share allocation arrangements for
non-executive Directors for the period of service from 1 October to 31 December
2003, as listed below.
Non Executive Director Ordinary Shares American Depositary
Shares
(ADS)
Sir Christopher Hogg 2938.8715
Mr Lawrence Culp 389.7510
Mr Crispin Davis 881.6614
Sir Peter Job 881.6614
Sir Ian Prosser 538.7931
Dr Ronaldo Schmitz 431.0345
The Company and the directors were informed of these allocations on 5 January
2004.
S M Bicknell
Company Secretary
5 January 2004
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.